Pentamidine Isethionate 300 mg Suppliers & Bulk Manufacturers

Available Forms: Injection / Inhalation solution

Available Strengths: 300 mg

Reference Brands: Pentam (USA), Nebupent (USA)

Category: Critical Care

Pentamidine Isethionate is a Critical Care product available as Injection / Inhalation solution in strengths 300 mg. It corresponds to the reference brands Pentam (USA), Nebupent (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Product Description:

Primidone is a well-established barbiturate-derived anticonvulsant medication used in the management of epilepsy and certain movement disorders. It is widely prescribed for the treatment of partial seizures and generalized seizures, including tonic-clonic seizures, and is also effective in the management of essential tremor. Marketed under various brand names, including Mysoline, primidone has remained an important therapeutic option for patients who require long-term seizure control or tremor reduction.

Clinically, primidone plays a significant role in the comprehensive management of complex, partial, and generalized seizures. Its antiepileptic activity is primarily mediated through its active metabolites, phenobarbital and phenylethylmalonamide, which enhance inhibitory neurotransmission in the central nervous system and help suppress abnormal neuronal firing. This mechanism contributes to stabilization of neuronal membranes and reduction in seizure frequency and severity.

Primidone therapy requires careful consideration of indications, contraindications, and potential adverse effects. It is commonly initiated at low doses and gradually titrated to achieve optimal therapeutic response while minimizing side effects such as sedation, dizziness, ataxia, nausea, and fatigue. Long-term use may require periodic monitoring due to the potential for hepatic, hematologic, or neurocognitive effects. Contraindications include hypersensitivity to barbiturates and caution is advised in patients with hepatic impairment, respiratory disorders, or a history of substance dependence.